Mar 14, 2019 -
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech stocks hitting 52-week highs on March 13)
Mar 14, 2019 - As expected, the European Commision approves Merck's (NYSE:MRK) Keytruda (pembrolizumab), combined with carboplatin and Celgene's (NASDAQ:CELG) Abraxane (paclitaxel protein-bound), for the first-line
Mar 14, 2019 - The European Commission (EC) approves Roche's (OTCQX:RHHBY) Hemlibra (emicizumab) for routine prophylaxis of bleeding episodes in people with severe haemophilia A (congenital factor VIII defic
Mar 08, 2019 - Roche (RHHBY) obtains approval for the label expansion of Tecentriq in Europe. The company also submits its sNDA for leukemia drug, Venclexta.
Mar 08, 2019 -
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs on March 7)
Mar 07, 2019 - Ecopetrol (EC) is set to invest $500 million toward exploring unconventional deposits in the 2019-2021 time frame, beginning with shale pilot programs in Colombia???s shale-rich Magadalena Valley basin.
Mar 05, 2019 - Autoliv (NYSE:ALV) announces that the European Commission completed its investigation into suppliers of occupant safety systems. The EU Commission has decided to impose a fine of €179M to the company
Feb 27, 2019 - Ecopetrol SA (NYSE:EC) Q4 2018 Earnings Conference Call February 27, 2019, 09:30 ET Company Participants Felipe Bayón - CEO Jorge Calvache - VP, Exploration Rafael Guzman - Technical Vice-President Al
Feb 12, 2019 - Seattle Genetics' (SGEN) partner, Takeda Pharmaceutical receives EC approval for Adcetris in combination with AVD to treat adults with previously untreated CD30+ stage IV cHL.
Feb 11, 2019 - The European Commission (EC) approves Bristol-Myers Squibb's (NYSE:BMY) Sprycel (dasatinib), combined with chemo, for the treatment pediatric patients with newly diagnosed Philadelphia chromos